BlueYard Capital
Kiuub. Your Product Team. On Subscription
Description: Engineering cells to make better mRNA.
Miro studied Bioengineering at Imperial College London and did research in systems and synthetic biology at Imperial College, Caltech, and Stanford during his undergraduate studies. Miro worked with TechBio VC investors in the US and Europe and consulted to public institutions and private enterprises in Central and Eastern Europe on life science R&D and business development. He was a graduate research affiliate at Stanford University, where he worked on synthetic biology-associated biosecurity matters. He a
Marian has a PhD in Molecular Biology at Oxford, where he focused on genetic engineering and cancer. He has more than 9 years of full-time wet-lab experience with cellular engineering. He worked at the top European research centres (including the University of Oxford, University of Gothenburg and Vienna BioCenter).
Paul has clinical and scientific expertise in transplant and heart failure, having published over 200 peer-reviewed scientific articles. He has been a serial entrepreneur and founder and Chief Medical Officer of medical device start-up companies, including Ardian; CHF Solutions; ARTritech Med; ROX Med and Advanced Heuristics. Paul has extensive executive experience: he served as a Medical Advisor to Medtronic and Merck Pharmaceutical, and as Entrepreneur-in-Residence at the White House, assigned to the FDA
BlueYard Capital
Kiuub. Your Product Team. On Subscription